C
Co-Diagnostics, Inc. (CODX)
NCM – Real vaqt narxi. Valyuta: USD
1.72
-0.18 (-9.47%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.88
+0.16 (9.30%)
Bozor oldidan: May 13, 2026, 7:04 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.72
-0.18 (-9.47%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.88
+0.16 (9.30%)
Bozor oldidan: May 13, 2026, 7:04 AM EDT
Co-Diagnostics, Inc. molekulyar diagnostika kompaniyasi sifatida faoliyat yuritadi, u Amerika Qo'shma Shtatlari va xalqaro miqyosda nuklein kislota molekulalarini aniqlash va/yoki tahlil qilish orqali ishlaydigan diagnostika testlari uchun ishlatiladigan reagentlarni ishlab chiqadi, ishlab chiqaradi va sotadi. Kompaniya bemorlarga tibbiy punktlarda va uyda polimeraza zanjir reaksiyasi (PCR) orqali sinov o'tkazish uchun mo'ljallangan Co-Dx PCR platformasini taklif etadi. Shuningdek, u COVID-19, gripp, sil, gepatit B va C, inson papillomavirusi, bezgak, chikungunya, isitma va zika virusi uchun PCR diagnostika testlarini taqdim etadi. Bundan tashqari, kompaniya kemiruvchilar tomonidan yuqtiriladigan kasalliklarni aniqlash uchun uchta multiplex testini, yuqumli kasalliklarni aniqlash uchun molekulyar vositalarni, saratonni skrining qilish uchun suyuq biopsiyani va qishloq xo'jaligi uchun mo'ljallangan vositalarni taklif etadi; o'simlik va hayvon genomlaridagi genetik xususiyatlarni aniqlaydigan testlar; va tibbiy punktlarda va uyda bemorlarga PCRni olib borish uchun mo'ljallangan portativ diagnostika qurilmasini taklif etadi. Kompaniya 2013-yilda tashkil etilgan va Yuta shtatining Solt-Leyk-Siti shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Mayuranki Almaula Ph.D. | Senior Vice President of Overseas Operations & Strategic Alliances |
| Mr. Andrew Benson | Head of Investor Relations |
| Mr. Brian L. Brown CPA | CFO & Company Secretary |
| Mr. Christopher Thurston | Chief Technology Officer |
| Mr. Dan Bohrer CPA | Vice President of Finance & Accounting |
| Mr. David Nielsen | Chief Operating Officer |
| Mr. Dwight H. Egan | Chairman, CEO & President |
| Mr. Richard David Abbott | President |
| Mr. Seth Egan | Chief Commercialization Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-31 | 8-K | form8-k.htm |
| 2026-03-31 | 10-K | form10-k.htm |
| 2026-03-10 | 8-K | form8-k.htm |
| 2026-01-21 | S-8 | forms-8.htm |
| 2026-01-13 | 8-K | form8-k.htm |
| 2025-12-30 | 8-K | form8-k.htm |
| 2025-12-05 | 8-K | form8-k.htm |
| 2025-11-13 | 8-K | form8-k.htm |
| 2025-11-10 | DEF 14A | formdef14a.htm |
| 2025-10-31 | PRE 14A | formpre14a.htm |